Stuart Friedrich

2.6k total citations
37 papers, 1.7k citations indexed

About

Stuart Friedrich is a scholar working on Oncology, Epidemiology and Physiology. According to data from OpenAlex, Stuart Friedrich has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Epidemiology and 9 papers in Physiology. Recurrent topics in Stuart Friedrich's work include Alzheimer's disease research and treatments (8 papers), Inflammatory Bowel Disease (8 papers) and Microscopic Colitis (8 papers). Stuart Friedrich is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Inflammatory Bowel Disease (8 papers) and Microscopic Colitis (8 papers). Stuart Friedrich collaborates with scholars based in United States, Canada and Singapore. Stuart Friedrich's co-authors include Eric Siemers, Bradley A. Saville, Yu‐Ling Cheng, Robert A. Dean, Ronald B. DeMattos, Steven M. Paul, Celedon Gonzales, Martin R. Farlow, Patrick C. May and Michael Heathman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Annals of Neurology.

In The Last Decade

Stuart Friedrich

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart Friedrich United States	19	724	369	356	310	288	37	1.7k
Robert McCormack United States	18	1.4k 1.9×	1.2k 3.1×	306 0.9×	261 0.8×	169 0.6×	39	3.1k
Cinzia Ciccacci Italy	25	171 0.2×	492 1.3×	169 0.5×	32 0.1×	296 1.0×	78	1.6k
Evelyn D. Lobo United States	14	126 0.2×	426 1.2×	221 0.6×	49 0.2×	229 0.8×	26	1.4k
Michael W. Conner United States	13	543 0.8×	652 1.8×	193 0.5×	76 0.2×	70 0.2×	21	1.6k
Scott J. Hebbring United States	26	98 0.1×	836 2.3×	99 0.3×	68 0.2×	98 0.3×	67	2.0k
Judong Shen United States	13	139 0.2×	580 1.6×	45 0.1×	108 0.3×	303 1.1×	30	1.6k
Adam Coffman United States	7	103 0.1×	937 2.5×	57 0.2×	232 0.7×	205 0.7×	11	1.6k
Jeanette McCarthy United States	23	129 0.2×	844 2.3×	95 0.3×	50 0.2×	203 0.7×	46	2.4k
David C. Underwood United States	19	805 1.1×	1.1k 2.9×	191 0.5×	56 0.2×	470 1.6×	46	2.2k

Countries citing papers authored by Stuart Friedrich

Since Specialization

Citations

This map shows the geographic impact of Stuart Friedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Friedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Friedrich more than expected).

Fields of papers citing papers by Stuart Friedrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Friedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Friedrich. The network helps show where Stuart Friedrich may publish in the future.

Co-authorship network of co-authors of Stuart Friedrich

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Friedrich. A scholar is included among the top collaborators of Stuart Friedrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Friedrich. Stuart Friedrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chua, Laiyi, et al.. (2025). Mirikizumab Pharmacokinetics and Exposure‐Response in Patients With Moderately‐To‐Severely Active Crohn's Disease: Results From Two Randomized Studies. Clinical and Translational Science. 18(8). e70320–e70320. 1 indexed citations

Chua, Laiyi, et al.. (2023). Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies. Clinical Pharmacokinetics. 62(10). 1479–1491. 15 indexed citations

Sandborn, William J., Marc Ferrante, Bal Raj Bhandari, et al.. (2019). Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis. Gastroenterology. 158(3). 537–549.e10. 179 indexed citations

Small, David S., Wei Zhang, Jane Royalty, et al.. (2015). A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State. Journal of Cardiovascular Pharmacology and Therapeutics. 20(5). 483–489. 8 indexed citations

Willis, Brian A., Stephen L. Lowe, Stuart Friedrich, et al.. (2012). The Effects on Metabolic Clearance when Administering a Potent CYP3A Autoinducer with the Prototypic CYP3A Inhibitor, Ketoconazole. Drug Metabolism and Disposition. 40(10). 1945–1952. 1 indexed citations

Bard, Frédérique, Michael Fox, Stuart Friedrich, et al.. (2012). Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice. Experimental Neurology. 238(1). 38–43. 40 indexed citations

Willis, Brian A., et al.. (2011). Semagacestat Pharmacokinetics Are Not Significantly Affected by Formulation, Food, or Time of Dosing in Healthy Participants. The Journal of Clinical Pharmacology. 52(6). 904–913. 9 indexed citations

Nakano, Masako, Brian A. Willis, Stuart Friedrich, et al.. (2011). Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of the Amyloid β Monoclonal Antibody Solanezumab in Japanese and White Patients With Mild to Moderate Alzheimer Disease. Clinical Neuropharmacology. 35(1). 25–29. 31 indexed citations

Siemers, Eric, Stuart Friedrich, Robert A. Dean, et al.. (2010). Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease. Clinical Neuropharmacology. 33(2). 67–73. 144 indexed citations

10.

Bateman, Randall J., Eric Siemers, Kwasi G. Mawuenyega, et al.. (2009). A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system. Annals of Neurology. 66(1). 48–54. 242 indexed citations

11.

Siemers, Eric, Robert A. Dean, Stuart Friedrich, et al.. (2007). Safety, Tolerability, and Effects on Plasma and Cerebrospinal Fluid Amyloid-β After Inhibition of γ-Secretase. Clinical Neuropharmacology. 30(6). 317–325. 121 indexed citations

12.

Friedrich, Stuart, et al.. (2002). Antibody-Directed Effector Cell Therapy of Tumors: Analysis and Optimization Using a Physiologically Based Pharmacokinetic Model. Neoplasia. 4(5). 449–463. 42 indexed citations

13.

Sequeira, Manuel, Mary E.P. Goad, Jamie Erickson, et al.. (2001). Efficacy and Mechanisms of Action of rmB7.2-Ig as an Antitumor Agent in Combination with Adriamycin and Cytoxan Chemotherapy. Clinical Immunology. 101(3). 303–314. 10 indexed citations

14.

Hausen, Bernard, J Klupp, Uwe Christians, et al.. (2001). COADMINISTRATION OF EITHER CYCLOSPORINE OR STEROIDS WITH HUMANIZED MONOCLONAL ANTIBODIES AGAINST CD80 AND CD86 SUCCESSFULLY PROLONG ALLOGRAFT SURVIVAL AFTER LIFE SUPPORTING RENAL TRANSPLANTATION IN CYNOMOLGUS MONKEYS1. Transplantation. 72(6). 1128–1137. 41 indexed citations

15.

Rosenzweig, Michael, MaryAnn DeMaria, David M. Harper, et al.. (1998). Increased rates of CD4⁺and CD8⁺T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proceedings of the National Academy of Sciences. 95(11). 6388–6393. 89 indexed citations

16.

Friedrich, Stuart, Bradley A. Saville, & Yu‐Ling Cheng. (1997). Drug Distribution in the Vitreous Humor of the Human Eye: The Effects of Aphakia and Changes in Retinal Permeability and Vitreous Diffusivity. Journal of Ocular Pharmacology and Therapeutics. 13(5). 445–459. 27 indexed citations

17.

Friedrich, Stuart, Yu‐Ling Cheng, & Bradley A. Saville. (1997). Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume. Current Eye Research. 16(7). 663–669. 79 indexed citations

18.

Friedrich, Stuart, Yu‐Ling Cheng, & Bradley A. Saville. (1997). Finite element modeling of drug distribution in the vitreous humor of the rabbit eye. Annals of Biomedical Engineering. 25(2). 303–314. 72 indexed citations

19.

Friedrich, Stuart, Bradley A. Saville, Yu‐Ling Cheng, & David S. Rootman. (1996). Pharmacokinetic Differences Between Ocular Inserts and Eyedrops. Journal of Ocular Pharmacology and Therapeutics. 12(1). 5–18. 19 indexed citations

20.

Friedrich, Stuart, Yu‐Ling Cheng, & Bradley A. Saville. (1993). Theoretical Corneal Permeation Model for Ionizable Drugs. Journal of Ocular Pharmacology and Therapeutics. 9(3). 229–249. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact